Cover Image

Combination Effect of Antituberculosis Drugs and Ethanolic Extract of Selected Medicinal Plants against Multi-Drug Resistant Mycobacterium tuberculosis Isolates

Adverse drug reaction and resistance to antituberculosis drugs remain the causes of tuberculosis therapeutic failure. This research aimed to find the combination effect of standard antituberculosis drugs with Hibiscus sabdariffa L., Kaempferia galanga L., and Piper crocatum N.E. Br against multi-dru...

Full description

Saved in:

Bibliographic Details
Main Authors:	Prabasiwi Nur Fauziyah (Author), Elin Yulinah Sukandar (Author), Dhyan Kusuma Ayuningtyas (Author)
Format:	Book
Published:	MDPI AG, 2017-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Toward antituberculosis drugs: in silico screening of synthetic compounds against Mycobacterium tuberculosis L,D-transpeptidase 2
by: Billones JB, et al.
Published: (2016)

ANTITUBERCULOSIS DRUG ALLERGY IN PATIENTS WITH MULTIDRUG-RESISTANT TUBERCULOSIS
by: B.B. MAYKANAEV, et al.
Published: (2021)

Frequency of multi-drug resistance and mutations in Mycobacterium tuberculosis isolates from Punjab state of India
by: Ritu Singhal, et al.
Published: (2017)

Frequency of multi-drug resistance and mutations in Mycobacterium tuberculosis isolates from Punjab state of India
by: Ritu Singhal, et al.
Published: (2019)

Computational Drug Repurposing for Antituberculosis Therapy: Discovery of Multi-Strain Inhibitors
by: Valeria V. Kleandrova, et al.
Published: (2021)

Effectiveness of new antituberculosis drugs in the treatment of children and adolescents with chemoresistant tuberculosis
by: M.І. Sakhelashvili, et al.
Published: (2024)

Multi-drug resistant Mycobacterium tuberculosis in Port Harcourt, Nigeria
by: Kome Otokunefor, et al.
Published: (2018)

Antibacterial activity of ethanolic extract and fraction of leaves of singawalang (Petiveria alliaceae) against resistant bacteria
by: Yani Mulyani, et al.
Published: (2011)

Investigation of bedaquiline resistance and genetic mutations in multi-drug resistant Mycobacterium tuberculosis clinical isolates in Chongqing, China
by: Yan Hu, et al.
Published: (2023)

Study of the pharmacokinetics of antituberculosis drug Biomairin
by: Sh. A. Shomurotov, et al.
Published: (2018)

Antituberculosis drug-induced hepatotoxicity in children
by: Peter R. Donald
Published: (2011)

The ethanolic extract of ashitaba stem (Angelica keskei [Miq.] Koidz) as future antituberculosis
by: Sri Agung Fitri Kusuma, et al.
Published: (2018)

Evaluation of therapeutic effectiveness of antituberculosis injection based on conversion time in drug-resistant tuberculosis
by: Emy Oktaviani, et al.
Published: (2024)

Clinical Efficacy of a Combination of Thymopentin and Antituberculosis Drugs in Treating Drug-Resistant Pulmonary Tuberculosis: Meta Analysis
by: Han YR, et al.
Published: (2022)

Pharmacokinetics and Drug-Drug Interactions of Abacavir and Lamuvudine Co-administered With Antituberculosis Drugs in HIV-Positive Children Treated for Multidrug-Resistant Tuberculosis
by: Louvina E. van der Laan, et al.
Published: (2021)

Drug Resistance Mechanisms in Mycobacterium tuberculosis
by: Juan Carlos Palomino, et al.
Published: (2014)

Molecular Analysis of Anti-Tuberculosis Drug Resistance of <i>Mycobacterium tuberculosis</i> Isolated in the Republic of Korea
by: Se-Mi Jeon, et al.
Published: (2023)

Combined antiretroviral and antituberculosis drug resistance following incarceration
by: Katharine Elizabeth Stott, et al.
Published: (2013)

Aureolic Acid Group of Agents as Potential Antituberculosis Drugs
by: Julia Bespyatykh, et al.
Published: (2020)

Seizures following Intoxication with a Common Antituberculosis Drug
by: Adnane Lahlou, et al.
Published: (2019)

The correlation of drug resistance and virulence in Mycobacterium tuberculosis
by: Lingjun Zhan, et al.
Published: (2020)

Primary and acquired drug resistance patterns of Mycobacterium tuberculosis isolates in India: A multicenter study
by: Jitendra Prasad Mathuria, et al.
Published: (2013)

Molecular docking studies of α-mangostin, γ-mangostin, and xanthone on peroxisome proliferator-activated receptor gamma diphenyl peptidase-4 enzyme, and aldose reductase enzyme as an antidiabetic drug candidate
by: Rifa'atul Mahmudah, et al.
Published: (2021)

New antituberculosis drugs: from clinical trial to programmatic use
by: Gina Gualano, et al.
Published: (2016)

Emergence of multi-drug-resistant Mycobacterium tuberculosis in Niger: A snapshot based on whole-genome sequencing.
by: Zelika Harouna Hamidou, et al.
Published: (2022)

Emergence of multi-drug-resistant Mycobacterium tuberculosis in Niger: A snapshot based on whole-genome sequencing
by: Zelika Harouna Hamidou, et al.
Published: (2022)

STUDI INTERAKSI OBAT-OBAT JANTUNG YANG DILAKUKAN TERHADAP ORANG SEHAT: TINJAUAN SISTEMATIS
by: Yunita Sumartin, et al.
Published: (2024)

Antituberculosis Targeted Drug Delivery as a Potential Future Treatment Approach
by: Mohd Khairul Nizam Mazlan, et al.
Published: (2021)

Regulation of mitogen-activated protein kinase signaling pathway and proinflammatory cytokines by ursolic acid in murine macrophages infected with <em>Mycobacterium avium</em>
by: Dian Ayu Eka Pitaloka, et al.
Published: (2020)

Drug sensitivity of clinical isolates of Mycobacterium tuberculosis and its association with bacterial genotype in the Somali region, Eastern Ethiopia
by: Getnet Worku, et al.
Published: (2022)

Analysis on Drug-Resistance-Associated Mutations among Multidrug-Resistant <i>Mycobacterium tuberculosis</i> Isolates in China
by: Hongbing Jia, et al.
Published: (2021)

EFEKTIVITAS-BIAYA PENGGUNAAN BEVACIZUMAB DAN RANIBIZUMAB SEBAGAI ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR PADA PASIEN DENGAN GANGGUAN MATA: TINJAUAN SISTEMATIS
by: Nur Sidik Cahyono, et al.
Published: (2024)

DETECTION OF DRUG ALLERGY ON ANTITUBERCULOSIS DRUGS USING LEUKOCYTES LYSIS SENSIBILIZATION REACTION AND TOTAL IMMUNOGLOBULIN E
by: E.V. DUDENKO, et al.
Published: (2018)

Antituberculosis drug resistance patterns in two regions of Turkey: a retrospective analysis
by: Oymak Sema F, et al.
Published: (2002)

Clinical risk factors for moderate and severe antituberculosis drug-induced liver injury
by: Quanxian Liu, et al.
Published: (2024)

ANTITUBERCULOSIS DRUG DOSAGE FORMS: RANGE, KEY BENEFITS AND PROSPECTS OF TECHNOLOGICAL IMPROVEMENT
by: M. E. Kim, et al.
Published: (2016)

Inhibitory Effect of Antituberculosis Drugs on Human Cytochrome P450-Mediated Activities
by: Yuki Nishimura, et al.
Published: (2004)

Incidence and characteristics of antituberculosis drug-induced hepatotoxicity in children: a preliminary study
by: Bina Akura, et al.
Published: (2009)

Whole genome sequencing for drug resistance determination in Mycobacterium tuberculosis
by: Shaheed V. Omar, et al.
Published: (2019)

Repurposing Cefazolin-Avibactam for the Treatment of Drug Resistant Mycobacterium tuberculosis
by: Shashikant Srivastava, et al.
Published: (2021)